Cerus Endovascular raises £1.5m from Spark Impact
Medical devices company Cerus Endovascular has completed a £1.5m funding round led by the North West Fund for Biomedical.
The vehicle, managed by Spark Impact on behalf of the £155m North West Fund, committed £600,000 to Cerus.
Life-sciences angel group Mid Atlantic Bio Angels participated in the round with a $500,000 capital injection.
The firm will use the funds to boost product development and accelerate pre-clinical trials prior to CE marking approval.
Company
Cerus is engaged in the design and development of interventional neuro-radiology devices and delivery systems for the treatment of neurovascular diseases. The firm is particularly focused on intracranial aneurysms through the use of an aneurysm occlusive device. Devices and systems are designed to be minimally invasive.
The company is headquartered in Oxford but will soon move to the Liverpool Science Park and was founded in 2011.
People
Penny Attridge is a senior investment director at Spark Impact and manages the North West Fund for Biomedical.
More on UK / Ireland
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater